William Allan Corp’s West Pharmaceutical WST Stock Holding History

William Allan Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.9M	Sell	13,228 -121	-0.9%	-$42.7K	2.46%	15
2026 Q2	$4.79M	Sell	13,349 -177	-1%	-$54.1K	2.34%	15
2026 Q1	$3.39M	Buy	13,526 +363	+3%	+$90.3K	2.01%	21
2025 Q4	$3.62M	Sell	13,163 -659	-5%	-$180K	2.05%	20
2025 Q3	$3.63M	Sell	13,822 -457	-3%	-$111K	2.03%	22
2025 Q2	$3.12M	Buy	14,279 +3,556	+33%	+$760K	1.82%	24
2025 Q1	$2.4M	Buy	10,723 +3,340	+45%	+$921K	1.51%	28
2024 Q4	$2.42M	Buy	7,383 +383	+5%	+$121K	1.49%	28
2024 Q3	$1.11M	Buy	7,000 +3,705	+112%	+$1.13M	0.69%	38
2024 Q2	$1.08M	Buy	+3,295	New	+$1.16M	0.73%	36

Other funds holding WST

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 16.58% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

William Allan Corp's WST Position: Q3 2026 in Review

William Allan Corp reduced its West Pharmaceutical (WST) stake by 0.91% in Q3 2026, selling an estimated $42.7K and leaving 13,228 shares worth $4.9M. The position accounts for 2.46% of the portfolio, ranked #15.

William Allan Corp first reported a position in WST in Q2 2024 and has held it in 10 quarters since. 289 funds tracked by Wall St. Rank hold WST as of Q3 2026.

William Allan Corp held 13,228 shares of West Pharmaceutical worth $4.9M as of Q3 2026.
William Allan Corp sold 121 West Pharmaceutical shares in Q3 2026, an estimated $42.7K.
West Pharmaceutical made up 2.46% of William Allan Corp's portfolio in Q3 2026, its #15 holding.
William Allan Corp first reported a position in West Pharmaceutical in Q2 2024 and has held it in 10 quarters since.
289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on William Allan Corp's 13F filing for Q3 2026, filed 14 Oct 2026.